Login
Communauté Vinci
Extérieur
Si votre nom d'utilisateur ne se termine pas par @vinci.be ou @student.vinci.be, utilisez le formulaire ci-dessous pour accéder à votre compte de lecteur.
Titre : | Hearing Features and Cochlear Implantation Outcomes in Patients With PathogenicMYO15AVariants : a Multicenter Observational Study (2022) |
Auteurs : | Pey-Yu Chen ; Cheng-Yu Tsai ; Che-Ming Wu ; Jiunn-Liang Wu ; Yi-Lu Li ; Kuang-Chao Chen ; Chung-Feng Hwang ; Hung-Ching Lin ; Yen-Fu Cheng ; Hung-Pin Wu ; Ming-Yu Lo ; Tien-Chen Liu ; Ting-Hua Yang ; Pei-Lung Chen ; Chuan-Jen Hsu ; Chen-Chi Wu, Auteur |
Type de document : | Article |
Dans : | Ear and hearing (Vol. 43, n°4, Juillet-Aout 2022) |
Article en page(s) : | p. 1198-1207 |
Note générale : | DOI: 10.1097/AUD.0000000000001171 |
Langues: | Anglais |
Descripteurs : |
HE Vinci Génotype ; Implants cochléaires ; PhénotypeAutres descripteurs Deficience auditive progressive |
Mots-clés: | MYO15A |
Résumé : |
Objectives: Recessive variants in theMYO15Agene constitute an important cause of sensorineural hearing impairment (SNHI). However, the clinical features ofMYO15A-related SNHI have not been systemically investigated. This study aimed to delineate the hearing features and outcomes in patients with pathogenicMYO15Avariants.
Design: This study recruited 40 patients with biallelicMYO15Avariants from 31 unrelated families. The patients were grouped based on the presence of N-terminal domain variants (N variants). The longitudinal audiological data and for those undergoing cochlear implantation, the auditory and speech performance with cochlear implants, were ascertained and compared between patients with different genotypes. Results: At the first audiometric examination, 32 patients (80.0%) presented with severe to profound SNHI. Patients with at least one allele of the N variant exhibited significantly better hearing levels than those with biallelic non-N variants (78.2 +/- 23.9 dBHL and 94.7 +/- 22.8 dBHL, respectively) (p= 0.033). Progressive SNHI was observed in 82.4% of patients with non-profound SNHI, in whom the average progression rate of hearing loss was 6.3 +/- 4.8 dBHL/year irrespective of the genotypes. Most of the 25 patients who underwent cochlear implantation exhibited favorable auditory and speech performances post-implantation. Conclusions: The hearing features of patients with biallelic pathogenicMYO15Avariants are characterized by severe to profound SNHI, rapid hearing progression, and favorable outcomes with cochlear implants. Periodic auditory monitoring is warranted for these patients to enable early intervention. |
Disponible en ligne : | Oui |
En ligne : | https://login.ezproxy.vinci.be/login?url=https://ovidsp.ovid.com/ovidweb.cgi?T=JS&NEWS=n&CSC=Y&PAGE=toc&D=yrovft&AN=00003446-000000000-00000 |